Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Heska Corporation

Heska Corporation (HSKA) Stock Overview

Explore Heska Corporation’s financial performance, market position, analyst ratings, and future outlook.

HSKA●NASDAQ
HealthcareMedical - Devices
$119.99
$0.00(0.00%)
U.S. Market opens in 3h 6m

Heska Corporation (HSKA)

Meyka AI Score

Z

Key Financials

Market Cap1.3B
P/E Ratio-67.41
EPS (TTM)$-1.92
ROE-0.04%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year Target$92.92

HSKA Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Heska Corporation (NASDAQ: HSKA) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Heska Corporation's NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of HSKA on the NASDAQ shows an RSI of N/A, suggesting the stock is in a an undetermined condition. Our forecasting models predict a 12-month price target of $92.92 for the NASDAQ listing.

Key metrics behind Heska Corporation's NASDAQ-traded stock include a P/E ratio of -67.41 and a market capitalization of 1.3B. Combined with our AI analysis, these give both institutional and retail investors a clear view of HSKA on the NASDAQ.

Price Performance (NASDAQ: HSKA)

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
N/A
3-Month Change
2.50%
6-Month Change
63.32%
Year-to-Date (YTD) Change
90.25%
1-Year Change
32.25%
3-Year Change
29.61%
5-Year Change
11.80%
All-Time (Max) Change
39.12%

Contact Information

https://www.antechdiagnostics.com/in-house-diagnostics
970 493 7272
3760 Rocky Mountain Avenue, Loveland, CO, 80538

Company Facts

8,080 Employees
IPO DateJul 1, 1997
CountryUS

Frequently Asked Questions